Drug intelligence / Profile preview

Sanostol

Development stage
Unknown
Lead developer
DR. KADE Health Care
Modality
Small Molecules
Administration
Oral
01

Overview

Sanostol is a comprehensive multivitamin product line developed and marketed by DR. KADE Health Care. It encompasses various formulations, including syrups, gummy bears, and lozenges, designed for vitamin supplementation in both children and adults. The product line includes Multi-Sanostol, which is approved as a medicinal product for the prevention of combined vitamin deficiency states in children from one year of age. The formulations typically contain a blend of essential micronutrients, including vitamins A, C, D, E, and the B-complex (B1, B2, B6, B12, niacin, biotin, folic acid, and pantothenic acid), with some variants enriched with iron and calcium. These vitamins and minerals act as essential cofactors and regulators in numerous metabolic processes, supporting normal physiological functions and preventing nutritional deficiencies.

Brand names
SanostolMulti-Sanostol
02

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Sanostol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanostol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call